PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

A Study to Understand What the Body Does to the Study Medicine Called PF-07220060 When Taken by Healthy Adults

Phase 1

Completed

Conditions: Healthy Participants

Interventions: Drug: Oral [14C]PF-07220060
Drug: Oral PF-07220060
Drug: IV [14C] PF-07220060

First Posted Date: 2024-02-20

Last Posted Date: 2024-05-14

Lead Sponsor: Pfizer

Target Recruit Count: 12

Registration Number: NCT06267963

Locations: 🇳🇱
PRA Health Sciences, Groningen, Netherlands

A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam

Phase 1

Completed

Conditions: Healthy Participants

Interventions: Drug: Midazolam
Drug: Vepdegestrant

First Posted Date: 2024-02-13

Last Posted Date: 2025-01-21

Lead Sponsor: Pfizer

Target Recruit Count: 15

Registration Number: NCT06256510

Locations: 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium

A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

Phase 2

Completed

Conditions: SARS-CoV-2 Infection
COVID-19
Influenza, Human

Interventions: Biological: BNT162b2 (Omi XBB.1.5)
Biological: RIV
Biological: BNT162b2 (Omi XBB.1.5)/RIV
Other: Normal saline placebo

First Posted Date: 2024-02-01

Last Posted Date: 2024-10-03

Lead Sponsor: Pfizer

Target Recruit Count: 645

Registration Number: NCT06237049

Locations: 🇺🇸
GW Vaccine Research Unit, Washington, District of Columbia, United States
🇺🇸
Optimal Research, Peoria, Illinois, United States
🇺🇸
GW Medical Faculty Associates, Washington, District of Columbia, United States

and more 24 locations

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

Phase 1

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Elranatamab
Drug: Iberdomide

First Posted Date: 2024-01-22

Last Posted Date: 2025-05-20

Lead Sponsor: Pfizer

Target Recruit Count: 87

Registration Number: NCT06215118

Locations: 🇦🇺
Calvary Mater Newcastle, Waratah, New South Wales, Australia
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

and more 28 locations

A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma

Phase 1

Completed

Conditions: Healthy Participants

Interventions: Drug: Spironolactone/Hydrochlorothiazide (25 mg/25 mg) film coated tablets from Viatris
Drug: Spironolactone/Hydrochlorothiazide (25 mg/25 mg) film coated tablets from Neolpharma.

First Posted Date: 2024-01-16

Last Posted Date: 2025-03-21

Lead Sponsor: Pfizer

Target Recruit Count: 42

Registration Number: NCT06205407

Locations: 🇺🇸
Clinical Trials of Texas, LLC, San Antonio, Texas, United States

A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

Phase 1

Active, not recruiting

Conditions: Breast Cancer

Interventions: Drug: vepdegestrant
Drug: PF-07220060

First Posted Date: 2024-01-16

Last Posted Date: 2025-05-01

Lead Sponsor: Pfizer

Target Recruit Count: 65

Registration Number: NCT06206837

Locations: 🇺🇸
Highlands Oncology, Rogers, Arkansas, United States
🇺🇸
Highlands Oncology Group, Springdale, Arkansas, United States
🇺🇸
Hoag Health Center Irvine, Irvine, California, United States

and more 50 locations

Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data

Active, not recruiting

Conditions: SARS-CoV-2
COVID-19 Vaccines

Interventions: Biological: Vaccination

First Posted Date: 2024-01-10

Last Posted Date: 2024-06-04

Lead Sponsor: Pfizer

Target Recruit Count: 1

Registration Number: NCT06199934

Locations: 🇺🇸
Pfizer Global Headquarters, New York, New York, United States

A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-07940367

First Posted Date: 2024-01-05

Last Posted Date: 2024-06-13

Lead Sponsor: Pfizer

Target Recruit Count: 40

Registration Number: NCT06190561

Locations: 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States

A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults

Phase 1

Active, not recruiting

Conditions: Pneumococcal Disease

Interventions: Biological: Multivalent Pneumococcal Vaccine - Formulation 1
Biological: Multivalent Pneumococcal Vaccine - Formulation 2
Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)
Biological: Licensed pneumococcal comparator vaccine

First Posted Date: 2023-12-26

Last Posted Date: 2024-12-30

Lead Sponsor: Pfizer

Target Recruit Count: 418

Registration Number: NCT06182124

Locations: 🇺🇸
Alliance for Multispecialty Research, LLC, Knoxville, Tennessee, United States
🇺🇸
Indago Research & Health Center, Inc, Hialeah, Florida, United States
🇺🇸
Clinical Research Atlanta, Stockbridge, Georgia, United States

and more 11 locations

A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza

Phase 1

Active, not recruiting

Conditions: Grippe
Influenza
Vaccines

Interventions: Biological: pdmFlu vaccine
Biological: Placebo
Biological: Licensed influenza vaccine

First Posted Date: 2023-12-21

Last Posted Date: 2025-06-03

Lead Sponsor: Pfizer

Target Recruit Count: 157

Registration Number: NCT06179446

Locations: 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States
🇺🇸
Research Centers of America ( Hollywood ), Hollywood, Florida, United States
🇺🇸
NYU Langone Health, New York, New York, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy